CME
Case 6: Implementing Current Guidelines and Best Practices for Monitoring and Mitigating Immune-Related Adverse Events
July 14, 2023
Host: Joshua E. Reuss, MD
The role of immunotherapy (IO) in the management of advanced and metastatic NSCLC continues to evolve, with several new frontline IO-based therapy regimens receiving FDA approval in the last few years. This program aims
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!